ArticleNPJ genomic medicine2025
Expanding carrier screening: beyond the genes, to include underrepresented ancestries.
Article in NPJ genomic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Translating genomic data into healthcare practice with the Singapore National Precision Medicine program.Nature genetics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Reproductive carrier screening has evolved beyond ethnic-specific testing to include diverse populations, yet gene selection varies considerably. In Singapore, genomic data analysis identified severe paediatric conditions amongst Chinese, Indian and Malay populations absent from existing screening panels. We developed a model leveraging data from 9051 participants to guide gene selection for carrier screening representative of Asian genetic diversity, focusing on severe paediatric-onset conditions prevalent in these populations. After evaluating severity, genotype-phenotype variability, clinical utility and technical feasibility, we identified 88 genes associated with recessive severe paediatric onset prevalent amongst Chinese, Indian and Malay populations, irrespective of carrier frequency. Including 24 additional genes from our registry resulted in a 105-gene panel, predicted to identify 0.44% at-risk couples, with 86 genes overlapping existing panels. Broadening criteria to include moderate severity conditions while limiting carrier frequencies to less than 1 in 200 reduced the panel to 59 genes, increasing predicted at-risk couples to 0.47%, due to higher carrier frequencies, yet introducing counselling complexities from greater clinical variability. Using local genomic data, we identified genetic conditions relevant to Asian populations for carrier screening. Expanding national genomic sequencing initiatives provides an opportunity to assess genetic condition prevalence across diverse ancestries, improving equity in carrier screening programmes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.